rs750971084

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_002047.4(GARS1):​c.1534G>A​(p.Ala512Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

GARS1
NM_002047.4 missense

Scores

2
13
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 9.96

Publications

0 publications found
Variant links:
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
GARS1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 2D
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • neuronopathy, distal hereditary motor, type 5A
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
  • spinal muscular atrophy, infantile, James type
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 7-30622383-G-A is Benign according to our data. Variant chr7-30622383-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 543209.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0000394 (6/152182) while in subpopulation AMR AF = 0.000393 (6/15274). AF 95% confidence interval is 0.00017. There are 0 homozygotes in GnomAd4. There are 3 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GARS1NM_002047.4 linkc.1534G>A p.Ala512Thr missense_variant Exon 12 of 17 ENST00000389266.8 NP_002038.2
GARS1NM_001316772.1 linkc.1372G>A p.Ala458Thr missense_variant Exon 12 of 17 NP_001303701.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GARS1ENST00000389266.8 linkc.1534G>A p.Ala512Thr missense_variant Exon 12 of 17 1 NM_002047.4 ENSP00000373918.3
GARS1ENST00000675651.1 linkc.1534G>A p.Ala512Thr missense_variant Exon 12 of 17 ENSP00000502513.1
GARS1ENST00000675810.1 linkc.1432G>A p.Ala478Thr missense_variant Exon 11 of 16 ENSP00000502743.1
GARS1ENST00000675693.1 linkc.1366G>A p.Ala456Thr missense_variant Exon 13 of 18 ENSP00000502174.1
GARS1ENST00000675051.1 linkc.1333G>A p.Ala445Thr missense_variant Exon 12 of 17 ENSP00000502296.1
GARS1ENST00000674815.1 linkc.1165G>A p.Ala389Thr missense_variant Exon 12 of 17 ENSP00000502799.1
GARS1ENST00000674851.1 linkc.1165G>A p.Ala389Thr missense_variant Exon 13 of 18 ENSP00000502451.1
GARS1ENST00000444666.6 linkn.1534G>A non_coding_transcript_exon_variant Exon 12 of 18 3 ENSP00000415447.2
GARS1ENST00000674616.1 linkn.*1248G>A non_coding_transcript_exon_variant Exon 13 of 18 ENSP00000502408.1
GARS1ENST00000674643.1 linkn.*634G>A non_coding_transcript_exon_variant Exon 13 of 17 ENSP00000501636.1
GARS1ENST00000674737.1 linkn.*872G>A non_coding_transcript_exon_variant Exon 13 of 18 ENSP00000502464.1
GARS1ENST00000674807.1 linkn.1534G>A non_coding_transcript_exon_variant Exon 12 of 16 ENSP00000502814.1
GARS1ENST00000675529.1 linkn.*1404G>A non_coding_transcript_exon_variant Exon 13 of 18 ENSP00000501655.1
GARS1ENST00000675859.1 linkn.1534G>A non_coding_transcript_exon_variant Exon 12 of 15 ENSP00000502033.1
GARS1ENST00000676088.1 linkn.*1476G>A non_coding_transcript_exon_variant Exon 14 of 19 ENSP00000501884.1
GARS1ENST00000676140.1 linkn.*479G>A non_coding_transcript_exon_variant Exon 12 of 17 ENSP00000502571.1
GARS1ENST00000676164.1 linkn.*985G>A non_coding_transcript_exon_variant Exon 12 of 17 ENSP00000501986.1
GARS1ENST00000676210.1 linkn.*823G>A non_coding_transcript_exon_variant Exon 13 of 18 ENSP00000502373.1
GARS1ENST00000676259.1 linkn.*966G>A non_coding_transcript_exon_variant Exon 12 of 17 ENSP00000501980.1
GARS1ENST00000676403.1 linkn.1534G>A non_coding_transcript_exon_variant Exon 12 of 16 ENSP00000502681.1
GARS1ENST00000674616.1 linkn.*1248G>A 3_prime_UTR_variant Exon 13 of 18 ENSP00000502408.1
GARS1ENST00000674643.1 linkn.*634G>A 3_prime_UTR_variant Exon 13 of 17 ENSP00000501636.1
GARS1ENST00000674737.1 linkn.*872G>A 3_prime_UTR_variant Exon 13 of 18 ENSP00000502464.1
GARS1ENST00000675529.1 linkn.*1404G>A 3_prime_UTR_variant Exon 13 of 18 ENSP00000501655.1
GARS1ENST00000676088.1 linkn.*1476G>A 3_prime_UTR_variant Exon 14 of 19 ENSP00000501884.1
GARS1ENST00000676140.1 linkn.*479G>A 3_prime_UTR_variant Exon 12 of 17 ENSP00000502571.1
GARS1ENST00000676164.1 linkn.*985G>A 3_prime_UTR_variant Exon 12 of 17 ENSP00000501986.1
GARS1ENST00000676210.1 linkn.*823G>A 3_prime_UTR_variant Exon 13 of 18 ENSP00000502373.1
GARS1ENST00000676259.1 linkn.*966G>A 3_prime_UTR_variant Exon 12 of 17 ENSP00000501980.1

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152182
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000521
AC:
13
AN:
249558
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000348
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000116
AC:
17
AN:
1461828
Hom.:
0
Cov.:
31
AF XY:
0.00000825
AC XY:
6
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.000335
AC:
15
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111976
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152182
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41446
American (AMR)
AF:
0.000393
AC:
6
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000248
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 09, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1534G>A (p.A512T) alteration is located in exon 12 (coding exon 12) of the GARS gene. This alteration results from a G to A substitution at nucleotide position 1534, causing the alanine (A) at amino acid position 512 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Charcot-Marie-Tooth disease type 2 Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Uncertain
0.051
T
BayesDel_noAF
Pathogenic
0.15
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.60
D
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.17
D
MetaRNN
Uncertain
0.54
D
MetaSVM
Uncertain
0.19
D
PhyloP100
10
PrimateAI
Uncertain
0.60
T
PROVEAN
Uncertain
-3.0
D
REVEL
Uncertain
0.57
Sift
Benign
0.045
D
Sift4G
Uncertain
0.040
D
Vest4
0.75
ClinPred
0.57
D
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.75
gMVP
0.63
Mutation Taster
=19/81
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs750971084; hg19: chr7-30661999; API